Autolus Therapeutics

AUTL | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.01

+$0.07 (+3.61%)

Sep 22, 2026, 11:21 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-287.53M	-220.66M	-208.38M	-148.84M	-142.1M	-142.09M
Depreciation & Amortization	9.81M	7.72M	6.57M	7.42M	8.46M	5.66M
Stock-Based Compensation	14.44M	15.47M	11.2M	12.01M	9.94M	20.11M
Other Working Capital	11.14M	-21.02M	801K	3.95M	5.95M	-29K
Other Non-Cash Items	32.1M	15.04M	45.72M	13.4M	1.77M	-1.5M
Deferred Income Tax	-286K	-185K	-986K	-268K	-72K	-1.34M
Change in Working Capital	-52.11M	-23.66M	292K	3.97M	4.14M	1.41M
Operating Cash Flow	-283.57M	-206.27M	-145.59M	-112.31M	-117.86M	-117.76M
Capital Expenditures	-27.13M	-34.82M	-10.99M	-10.84M	-8.86M	-14.68M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-242.62M	-359.73M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	428.21M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-8.09M	-12.74M	n/a	n/a	n/a	n/a
Investing Cash Flow	158.46M	-394.55M	-10.99M	-10.84M	-8.86M	-14.68M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-4.34M	39.58M	-883K	59.76M	38.16M	-79.75M
Financial Cash Flow	-4.34M	589.55M	-883K	223.61M	284.06M	74.42M
Net Cash Flow	-123.17M	-11.53M	-142.43M	72.09M	156.59M	-57.35M
Free Cash Flow	-310.7M	-241.09M	-156.57M	-123.15M	-126.72M	-132.44M
Adj. Free Cash Flow	-325.14M	-256.56M	-167.78M	-135.16M	-136.66M	-152.55M
Maintenance CapEx	n/a	n/a	-10.99M	n/a	-8.86M	-14.68M
Growth CapEx	-27.13M	-34.82M	n/a	-10.84M	n/a	n/a
Owner Earnings	-283.57M	-206.27M	-156.57M	-112.31M	-126.72M	-132.44M